Literature DB >> 21977057

DNA vaccine: a promising new approach for chronic hepatitis B therapy.

Lucyna Cova1.   

Abstract

Entities:  

Year:  2007        PMID： 21977057      PMCID： PMC3184607          DOI： 10.2217/17460794.2.5.421

Source DB:  PubMed          Journal:  Future Virol        ISSN： 1746-0794            Impact factor:   1.831


× No keyword cloud information.
  14 in total

1.  A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.

Authors:  Shawn Babiuk; Cemaine Tsang; Sylvia van Drunen Littel-van den Hurk; Lorne A Babiuk; Philip J Griebel
Journal:  Bioelectrochemistry       Date:  2006-10-14       Impact factor: 5.373

Review 2.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.

Authors:  C Rollier; C Charollois; C Jamard; C Trepo; L Cova
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 4.  DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

Authors:  M L Michel; D Loirat
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

5.  Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.

Authors:  F Siegel; M Lu; M Roggendorf
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Authors:  M Triyatni; A R Jilbert; M Qiao; D S Miller; C J Burrell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 7.  Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?

Authors:  Fabien Zoulim
Journal:  Antivir Chem Chemother       Date:  2004-11

8.  Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.

Authors:  Maryline Mancini-Bourgine; Hélène Fontaine; Daniel Scott-Algara; Stanislas Pol; Christian Bréchot; Marie-Louise Michel
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

9.  Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Patricia L Marion; Richard J Colonno; Ieva Kotlarski; Allison R Jilbert
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.

Authors:  S-H Yang; C-G Lee; S-H Park; S-J Im; Y-M Kim; J-M Son; J-S Wang; S-K Yoon; M-K Song; A Ambrozaitis; N Kharchenko; Y-D Yun; C-M Kim; C-Y Kim; S-H Lee; B-M Kim; W-B Kim; Y-C Sung
Journal:  Gene Ther       Date:  2006-03-09       Impact factor: 5.250
View more
  2 in total

Review 1.  Prevention of hepatitis B virus infection: from the past to the future.

Authors:  R Orlando; M Foggia; A E Maraolo; S Mascolo; G Palmiero; O Tambaro; G Tosone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-13       Impact factor: 3.267

2.  Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice.

Authors:  Jian-Hua Chen; Yong-Sheng Yu; Hong-Hong Liu; Xiao-Hua Chen; Min Xi; Guo-Qing Zang; Zheng-Hao Tang
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.